Pharmacology British Journal of Pharmacology

Amylin-Type Receptor Joins CGRP Receptor in Driving Migraine Light Aversion, but Not Diarrhoea, in Mice

  • In mice, CGRP and amylin each triggered light aversion, a migraine-like behaviour, and diarrhoea.
  • The CGRP receptor blocker olcegepant failed to stop CGRP-driven light aversion, whereas the amylin-type antagonist AC187 helped partly; only the combination fully reversed it.
  • Diarrhoea tracked mainly with the canonical CGRP receptor, suggesting AMY1 is a distinct target for photophobia.
Points Based on the abstract

Olcegepant alone failing to block CGRP-driven light aversion, while it fully blocks periorbital allodynia, is the useful dissociation: it implies photophobia runs through AMY1, not just the canonical receptor. But AC187 is a weakly selective peptide antagonist, so I'd confirm with a second AMY1-selective tool or knockout, plus exposure data, before calling AMY1 a standalone target.